The cost associated with administering risperidone long-acting injections in the Australian community

Table 5 Average saving per two-weekly administration of risperidone LAI avoided (by ASGC region and nationally)

Saving per treatment setting and ASGC region	ASGC region: Major Cities	ASGC region: Inner Regional	ASGC region: Outer Regional	ASGC region: Remote & Very Remote
Setting 1: Patients attending a clinic^b	$41.03	$37.89	$52.83	$59.49
Setting 2: Mobile Outreach Visits (1 staff)	$15.37^a	$15.79^a	$25.98^a	$24.84^a
Setting 3: Mobile Outreach Visits (> 1 staff)	$15.01^a	$12.65^a	$13.30^a	$30.99^a
Total Savings ($) by ASGC region (Savings Setting 1 + Savings Setting 2 + Savings Setting 3)	$71.41	$66.33	$92.10	$115.33
National risperidone LAI unit sales weighted by ASGC region (%)^b	62.4%	19.5%	14.0%	4.2%
Savings ($) from two-weekly visits avoided (Weighted)	$44.55	$12.91	$12.88	$4.80
National average saving ($) per two-weekly injection avoided			$75.14

ISSN: 1472-6963